ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hepatitis"

  • 2022 American Transplant Congress

    The Paradox of Lifestyle – Related Liver Disease: ASH and NASH

    N. Kemmer1, J. Buggs2

    1Transplant Hepatology, Tampa General Hospital, Tampa, FL, 2Transplant Surgery, Tampa General Hospital, Tampa, FL

    *Purpose: In the last decade, the burden of lifestyle-related chronic disease has been on the rise and is considered a growing serious public health concern.…
  • 2022 American Transplant Congress

    Characteristics and Outcomes of Patients Admitted for Acute Alcoholic Hepatitis Before and During the COVID-19 Pandemic

    M. S. Anderson1, S. Uttal2, M. Bertha3, K. Jencks2, H. Asefah2, A. Gustafson3, K. N. Truitt3, P. Maddur3, J. Mellinger2

    1Surgery, Michigan Medicine, Ann Arbor, MI, 2Internal Medicine, Michigan Medicine, Ann Arbor, MI, 3Internal Medicine, Northwestern Memorial Hospital, Chicago, IL

    *Purpose: Despite known increases in alcohol use, changes in alcohol-associated liver disease rates during COVID-19 have not been well characterized. We compared the incidence and…
  • 2022 American Transplant Congress

    Variable Course of Hepatitis A Virus Infection in Solid Organ Transplant Recipients

    A. Vostal1, J. Husson2, A. Shishido1, N. Jakhete3, E. Moore4, X. Wen5, A. Amoroso2, R. Meier6, E. Wilson2, K. K. Saharia2

    1Div. of Infectious Diseases, Univ. of Maryland Medical Center, Baltimore, MD, 2Div. of Infectious Diseases, Univ. of Maryland School of Medicine and Institute of Human Virology, Baltimore, MD, 3Div. of Hepatology, Univ. of Maryland School of Medicine, Baltimore, MD, 4Dept of Surgery, Brooklyn Hospital Center, Brooklyn, NY, 5Dept. of Surgery, Univ. of Florida, Gainesville, FL, 6Dept. of Surgery, Univ. of Maryland School of Medicine, Baltimore, MD

    *Purpose: Although Hepatitis A virus (HAV) infection is typically a self-limited disease in immunocompetent individuals, the natural history and viral kinetics of HAV in solid…
  • 2021 American Transplant Congress

    Varicella Hepatitis Mimicking Immune Checkpoint Inhibitor-induced Liver Toxicity

    M. J. Weiss1, X. Zhang2, E. K. Spengler1

    1Gastroenterology and Hepatology, University of Wisconsin, Madison, WI, 2Pathology, University of Wisconsin, Madison, WI

    *Purpose: Nivolumab is an anti-PD-1 monoclonal antibody belonging to a class of immune checkpoint inhibitors (ICI) used for many malignancies. A major limitation to their…
  • 2021 American Transplant Congress

    Algorithms to Identify Alcoholic Hepatitis Hospitalizations in Patients with Cirrhosis

    S. Panchal1, D. Kaplan2, D. Goldberg3, N. Mahmud2

    1Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, 2Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, PA, 3Gastroenterology, University of Miami Miller School of Medicine, Miami, FL

    *Purpose: With the rising proportion of patients receiving liver transplantation for alcoholic hepatitis, it is important to identify methods of ascertaining hospitalizations with alcoholic hepatitis…
  • 2021 American Transplant Congress

    Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single Center Experience

    M. Carter1, M. Fitzmaurice2, S. Yeddula2, A. Singh2, S. Nagai2, S. Jafri2

    1Wayne State University School of Medicine, Detroit, MI, 2Henry Ford Health System, Detroit, MI

    *Purpose: Transplant-related Hepatitis E virus (HEV) infection is a rarely recognized entity with significant clinical importance given potential for chronic hepatitis post-transplant. We evaluated HEV…
  • 2021 American Transplant Congress

    Prevalence of Hepatitis E Virus Infection in Solid Organ Transplant Recipients: A Systematic Review and Meta-analysis

    P. Hansrivijit1, A. Trongtorsak2, B. Boonpheng3, C. Thongprayoon4, W. Cheungpasitporn4

    1Department of Internal Medicine, UPMC Pinnacle, Harrisburg, PA, 2Department of Internal Medicine, Amita Health Saint Francis Hospital, Evanston, IL, 3Division of Nephrology, David Geffen School of Medicine, University of California, Los Angeles, CA, 4Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN

    *Purpose: Hepatitis E virus (HEV) infection is an underdiagnosed disease due to the use of serological assays with low sensitivity. Although most patients with HEV…
  • 2021 American Transplant Congress

    Donor Derived Transmissions 2019: Analysis of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC)

    L. Danziger-Isakov1, M. G. Michaels1, A. Agarwal1, S. Aslam1, K. Dunn1, J. Goldman1, D. Levine1, C. Marboe1, G. Marklin1, S. Pouch1, M. Rana1, R. Razonable1, H. L. Stevenson1, H. S. Te1, A. Woolley1, E. Ward2, C. Jett2, L. Cartwright2, R. La Hoz1

    1OPTN DTAC, Richmond, VA, 2UNOS, Richmond, VA

    *Purpose: The OPTN DTAC, a multidisciplinary group, evaluates potential donor derived transmission events (PDDTE), mostly infections (I) & malignancies (M), to assess the likelihood of…
  • 2020 American Transplant Congress

    IM Naltrexone Post Liver Transplant for Alcoholic Hepatitis Patients to Prevent Relapse

    A. Flecha

    Transplant Surgery, Montefiore Medical Center, Bronx, NY

    *Purpose: The number of patients requiring liver transplants due to Hepatitis C Virus is declining due to the new treatment options, and the growing number…
  • 2020 American Transplant Congress

    Outcome of Hepatitis B Virus DNA-Positive Liver Transplantation in Hepatitis B Virus/Hepatitis D Virus Co-Infected Recipient Treated with High Dose Hepatitis B Immune Globulin: A Case Report

    M. B. Hammami1, M. Haris1, L. Toman1, N. Danis1, B. Saberi2, E. King3, J. Garonzik-Wang3, B. Philosophe3, A. M. Cameron3, A. Gurakar1

    1Gastroenterology and Hepatology, Johns Hopkins, Baltimore, MD, 2Gastroenterology and Hepatology, Icahn School of Medicine at Mount Sinai, New York, NY, 3Transplant Surgery, Johns Hopkins, Baltimore, MD

    *Purpose: Introduction: While common in Asian countries, liver transplantation (LT) for patients with hepatitis B virus (HBV)/hepatitis D virus (HDV) co-infection is rare in the…
  • 1
  • 2
  • 3
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2023 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences